ASCENTAGE PHARMA GR-ADR (AAPG) Stock Price & Overview
NASDAQ:AAPG
Current stock price
The current stock price of AAPG is 22.34 USD. Today AAPG is down by -11.1%. In the past month the price decreased by -0.18%. In the past year, price decreased by -15.04%.
AAPG Key Statistics
- Market Cap
- 2.077B
- P/E
- N/A
- Fwd P/E
- 31.57
- EPS (TTM)
- -2.04
- Dividend Yield
- N/A
AAPG Stock Performance
AAPG Stock Chart
AAPG Technical Analysis
ChartMill assigns a technical rating of 2 / 10 to AAPG. When comparing the yearly performance of all stocks, AAPG is a bad performer in the overall market: 82.93% of all stocks are doing better.
AAPG Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to AAPG. AAPG has a bad profitability rating. Also its financial health evaluation is rather negative.
AAPG Earnings
AAPG Forecast & Estimates
13 analysts have analysed AAPG and the average price target is 49.82 USD. This implies a price increase of 123% is expected in the next year compared to the current price of 22.34.
For the next year, analysts expect an EPS growth of 138.64% and a revenue growth 274.67% for AAPG
AAPG Groups
Sector & Classification
AAPG Financial Highlights
Over the last trailing twelve months AAPG reported a non-GAAP Earnings per Share(EPS) of -2.04. The EPS decreased by -176.65% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -38.05% | ||
| ROE | -174.06% | ||
| Debt/Equity | 1.99 |
AAPG Ownership
AAPG Competitors/Peers
| Symbol | Company Name | Technical Rating | Fundamental Rating | FPE | Market Cap |
|---|---|---|---|---|---|
| ABBV | ABBVIE INC | 13.55 | 355.432B | ||
| AMGN | AMGEN INC | 15.27 | 188.147B | ||
| GILD | GILEAD SCIENCES INC | 15.12 | 165.877B | ||
| VRTX | VERTEX PHARMACEUTICALS INC | 22.34 | 110.672B | ||
| REGN | REGENERON PHARMACEUTICALS | 16.34 | 80.984B | ||
| ALNY | ALNYLAM PHARMACEUTICALS INC | 45.97 | 41.869B | ||
| INSM | INSMED INC | N/A | 31.046B | ||
| NTRA | NATERA INC | N/A | 28.508B | ||
| BIIB | BIOGEN INC | 11.65 | 27.573B | ||
| RVMD | REVOLUTION MEDICINES INC | N/A | 26.65B | ||
| UTHR | UNITED THERAPEUTICS CORP | 19.6 | 25.108B | ||
| MRNA | MODERNA INC | N/A | 20.96B | ||
| INCY | INCYTE CORP | 12.33 | 19B |
Related stock screener links
View all stocks in the Biotechnology Industry | View all stocks in the Health Care Sector | View all stocks on the Nasdaq Exchange | Find stocks with similar TA and Setup ratings on the USA exchanges | Find stocks with similar Fundamental rating on the USA exchanges | Find the competitors with the best technical ratings on the USA exchanges | Find the competitors with the best fundamentals on the USA exchanges | Find the competitors with the best valuation on the USA exchanges | Find the competitors with the best dividend on the USA exchanges | Find the competitors with the best analyst ratings on the USA exchanges
About AAPG
Company Profile
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. The company is headquartered in Suzhou, Jiangsu and currently employs 605 full-time employees. The company went IPO on 2019-10-28. The firm's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The firm's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The firm primarily conducts its businesses in domestic market.
Company Info
IPO: 2019-10-28
ASCENTAGE PHARMA GR-ADR
68 Xinqing Road, Suzhou Industrial Park
Suzhou JIANGSU CN
Employees: 605
ASCENTAGE PHARMA GR-ADR / AAPG FAQ
What does AAPG do?
Ascentage Pharma Group International Co., Ltd. is a clinical-stage biotechnology company. The company is headquartered in Suzhou, Jiangsu and currently employs 605 full-time employees. The company went IPO on 2019-10-28. The firm's main products include Olverembatinib (HQP1351), Lisaftoclax (APG-2575), Alrizomadlin (APG-115), Pelcitoclax (APG-1252), APG-5918, and APG-2449. The firm's products are primarily used to treat chronic myeloid leukemia (CML), acute myeloid leukemia (AML), chronic lymphocytic leukemia (CLL), acute lymphoblastic leukemia (ALL), myelodysplastic syndrome (MDS) and multiple myeloma (MM). The firm primarily conducts its businesses in domestic market.
What is the current price of AAPG stock?
The current stock price of AAPG is 22.34 USD. The price decreased by -11.1% in the last trading session.
Does AAPG stock pay dividends?
AAPG does not pay a dividend.
What is the ChartMill technical and fundamental rating of AAPG stock?
AAPG has a ChartMill Technical rating of 2 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Where is ASCENTAGE PHARMA GR-ADR (AAPG) stock traded?
AAPG stock is listed on the Nasdaq exchange.
Can you provide the PE ratio for AAPG stock?
ASCENTAGE PHARMA GR-ADR (AAPG) does not have a PE ratio as the earnings reported over the last twelve months were negative (-2.04).
How many employees does ASCENTAGE PHARMA GR-ADR have?
ASCENTAGE PHARMA GR-ADR (AAPG) currently has 605 employees.